Skip to main content
Premium Trial:

Request an Annual Quote

GenVault Raises $13M in VC Funding

NEW YORK (GenomeWeb News) – GenVault has closed a $13 million round of financing with venture capital investors, the Carlsbad, Calif.-based firm said today.
GenVault said that it would use the funds to accelerate commercialization of its technologies for room temperature biosample preservation, storage and distribution for biobanking, translational medicine, and applied testing applications.
The round of financing was led by Montagu Newhall Associates, with additional investments coming from existing investors Domain Associates, QuestMark Partners, and Cross Creek Capital. C. Ashton Newhall, a partner with Montagu Newhall, will join GenVault’s board of directors, the firm said.
GenVault said that its dry state platform “enables the extraction, preservation, recovery, and distribution of DNA at room temperature.” The firm also plans to develop systems for protein and RNA sample management.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.